A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase (Q40038968)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 November 2007
edit
Language Label Description Also known as
English
A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase
scientific article published on 21 November 2007

    Statements

    A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase (English)
    Bernard Barlaam
    Peter Ballard
    Robert H Bradbury
    Richard Ducray
    Hervé Germain
    D Mark Hickinson
    Kevin Hudson
    Jason G Kettle
    Teresa Klinowska
    Françoise Magnien
    Donald J Ogilvie
    Annie Olivier
    Stuart E Pearson
    Abid Suleman
    Cath B Trigwell
    Michel Vautier
    Robin D Whittaker
    Robin Wood
    21 November 2007
    674-678

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit